TP53 and acute myeloid leukemia: In conclusion, we proposed a hypothesis that ATPR inhibits E2A expression in AML cells by interacting with retinoic acid receptor alpha (RARα), thereby reducing the expression of the downstream target gene c‐Myc, activating the P53 pathway and inducing cell differentiation and cycle arrest.